PICO Portalanswers from OpenAlex & ORCID
Corey J. Langer
ResearcherPublications, citations & collaboration network
Corey J. Langer is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Corey J. Langer have?
PICO Portalindexed works
Corey J. Langer has 865 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Corey J. Langer have?
PICO Portalcitation count
Corey J. Langer has 40,142 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Corey J. Langer?
PICO Portalh-index
Corey J. Langer has an h-index of 90 in OpenAlex.
What is the i10-index of Corey J. Langer?
PICO Portali10-index
Corey J. Langer has an i10-index of 338 in OpenAlex.
What is the ORCID of Corey J. Langer?
PICO Portalorcid
The ORCID for Corey J. Langer is on the source record.
What is the OpenAlex record for Corey J. Langer?
PICO Portalopenalex
The OpenAlex for Corey J. Langer is on the source record.
What are the most-cited papers on Corey J. Langer?
PICO Portalmost cited works
Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
Walter J. Curran, Rebecca Paulus, Corey J. Langer, R. Komaki, Jong Seok Lee, Stephen L. Hauser, B. Movsas, Todd H. Wasserman, Seth A. Rosenthal, Elizabeth Gore, Mitchell Machtay, William T. Sause, James D. Cox
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
Dong‐Wan Kim, Marcello Tiseo, Myung‐Ju Ahn, Karen L. Reckamp, Karin Holmskov Hansen, Sang‐We Kim, Rudolf M. Huber, Howard West, Harry J.M. Groen, Maximilian J. Hochmair, Natasha B. Leighl, Scott Gettinger, Corey J. Langer, Luis G. Paz-Ares Rodríguez, Egbert F. Smit, Edward S. Kim, William M. Reichmann, Frank G. Haluska, David Kerstein, D. Ross Camidge
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
Scott Gettinger, Lyudmila Bazhenova, Corey J. Langer, Ravi Salgia, Kathryn A. Gold, Rafael Rosell, Alice T. Shaw, Glen J. Weiss, Meera Tugnait, Narayana I. Narasimhan, David J. Dorer, David Kerstein, Victor M. Rivera, Timothy Piers Clackson, Frank G. Haluska, David Ross Camidge